Amgen, Wyeth To Fight Suit Over Aranesp, Enbrel
A qui tam suit against Amgen Inc., Wyeth Pharmaceuticals Inc. and others over allegedly unlawful marketing activities in connection with Amgen's anemia drug Aranesp and the psoriasis and arthritis drug Enbrel,...To view the full article, register now.
Already a subscriber? Click here to view full article